Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A

Hamid A Merchant1, Harris M Shoaib2, Jaweria Tazeen1

  • 1Faculty of Pharmacy, University Road, 75270, Karachi, Pakistan.

AAPS Pharmscitech
|March 15, 2017
PubMed

Insights

Developing a once-daily sustained-release tablet of cefpodoxime proxetil using HPMC enhances patient compliance and bacterial killing rates. This formulation effectively controls drug release for 24 hours, offering a promising alternative for improved therapeutic outcomes.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Pharmacokinetics

Background:

  • Patient compliance with antibiotic regimens is often limited by frequent dosing schedules.
  • Cefpodoxime proxetil is an effective antibiotic, but its conventional dosing may impact adherence.
  • Sustained-release formulations offer potential for improved patient compliance and therapeutic efficacy.

Purpose of the Study:

  • To develop and characterize a once-daily sustained-release tablet formulation of cefpodoxime proxetil.
  • To evaluate the in vitro drug release profile and kinetics of the developed formulation.
  • To assess the suitability of the formulation for improved patient compliance.

Main Methods:

  • Formulation of cefpodoxime proxetil sustained-release tablets utilizing a hydrophilic HPMC matrix.
  • Evaluation of pharmacotechnical properties including assay and tablet characteristics.
  • In vitro dissolution studies conducted over 24 hours.
  • Analysis of drug release kinetics using Higuchi, Korsmeyer-Peppas, and Hixson-Crowell models.

Main Results:

  • The HPMC matrix effectively controlled cefpodoxime proxetil release for 24 hours, achieving a sustained-release profile.
  • The formulation exhibited acceptable pharmacotechnical properties and met assay requirements.
  • In vitro dissolution data closely matched theoretical release profiles, with drug release best described by Higuchi's equation (r²=0.9734).
  • Korsmeyer-Pappas analysis indicated an anomalous diffusion mechanism (n=0.57), suggesting combined diffusion and erosion control.

Conclusions:

  • A once-daily sustained-release tablet of cefpodoxime proxetil can be effectively developed using an HPMC matrix.
  • The formulation demonstrates favorable in vitro release characteristics, supporting improved patient compliance and potentially enhanced therapeutic outcomes.
  • The drug release mechanism involves a combination of diffusion and matrix erosion, providing a controlled release profile over 24 hours.

Related Concept Videos

Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
88
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
69
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
436
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
803
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
677
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
403